Complementary Roles of Farnesoid X Receptor, Pregnane X Receptor, and Constitutive Androstane Receptor in Protection against Bile Acid Toxicity
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
The nuclear receptors, farnesoid X receptor (FXR) and pregnane X receptor (PXR), are important in maintaining bile acid homeostasis. Deletion of both FXR and PXR in vivo by cross-breeding B6;129-Fxrtm1Gonz (FXR-null) and B6;129-Pxrtm1Glaxo-Wellcome (PXR-null) mice revealed a more severe disruption of bile acid, cholesterol, and lipid homeostasis in B6;129-Fxrtm1Gonz Pxrtm1Glaxo-Wellcome (FXR-PXR double null or FPXR-null) mice fed a 1% cholic acid (CA) diet. Hepatic expression of the constitutive androstane receptor (CAR) and its target genes was induced in FXR- and FPXR-null mice fed the CA diet. To test whether up-regulation of CAR represents a means of protection against bile acid toxicity to compensate for the loss of FXR and PXR, animals were pretreated with CAR activators, phenobarbital or 1,4-bis[2-(3,5-dichlorpyridyloxy)]benzene (TCPOBOP), followed by the CA diet. A role for CAR in protection against bile acid toxicity was confirmed by a marked reduction of serum bile acid and bilirubin concentrations, with an elevation of the expression of the hepatic genes involved in bile acid and/or bilirubin metabolism and excretion (CYP2B, CYP3A, MRP2, MRP3, UGT1A, and glutathione S-transferase alpha), following pretreatment with phenobarbital or TCPOBOP. In summary, the current study demonstrates a critical and combined role of FXR and PXR in maintaining not only bile acid but also cholesterol and lipid homeostasis in vivo. Furthermore, FXR, PXR, and CAR protect against hepatic bile acid toxicity in a complementary manner, suggesting that they serve as redundant but distinct layers of defense to prevent overt hepatic damage by bile acids during cholestasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated BAs can activate the FXR, pregnane X receptor (PXR), and CAR.54,55”
From Constitutive Androstane Receptor Regulates Bile Acid Homeostasis and Metabolism During Liver Regeneration (2026) · cites this paper as [55]
In the citing paper
“Intrahepatic cholestasis can also activate the constitutive androstane receptor (CAR, NR1I3) (Guo et al., 2003; Huang et al., 2005; Ma et al., 2009; Zhang et al., 2004)”
From Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis (2016) · cites this paper as Guo et al., 2003
In the citing paper
“We and others have previously demonstrated that elevated bile acids, as observed in mice lacking circadian homeostasis, activates CAR (Guo et al., 2003; Huang et al., 2005; Ma et al., 2009; Zhang et al., 2004)”
From Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis (2016) · cites this paper as Guo et al., 2003
In the citing paper
“which is well known as a potent tumor promoter that drives non-genotoxic hepatocarcinogenesis (Guo et al., 2003; Huang et al., 2005; Yamamoto et al., 2004; Zhang et al., 2004).”
From Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis (2016) · cites this paper as Guo et al., 2003
Citations
Cites
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
Self-citationA regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Self-citationTargeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819
Self-citationEndogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR
Wang, H., Chen, J., Hollister, K., Sowers, L. C., & Forman, B. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80348-2 · Cited by 1,636
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
Staudinger, J. L., Goodwin, B., Jones, S. A., Hawkins-Brown, D., MacKenzie, K. I., LaTour, A., Liu, Y., Klaassen, C. D., Brown, K. K., Reinhard, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051551698 · Cited by 1,379
Self-citationIdentification of a nuclear receptor that is activated by farnesol metabolites
Forman, B. M., Goode, E., Chen, J., Oro, A. E., Bradley, D. J., Perlmann, T., Noonan, D. J., Burka, L. T., McMorris, T., Lamph, W. W., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90530-8 · Cited by 1,210
Vitamin D Receptor As an Intestinal Bile Acid Sensor
Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., Haussler, M. R., & Mangelsdorf, D. J. (2002) · Science · doi:10.1126/science.1070477 · Cited by 1,176
An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids
Xie, W., Radominska-Pandya, A., Shi, Y., Simon, C. M., Nelson, M. C., Ong, E. S., Waxman, D. J., & Evans, R. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051014398 · Cited by 757
Maglich, J. M., Stoltz, C. M., Goodwin, B., Hawkins-Brown, D., Moore, J. T., & Kliewer, S. A. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.3.638 · Cited by 654
Self-citation
Research works printed but not linked: 2
- Hofmann, 1995, Ital. J. Gastroenterol., 27, 106
- Seol, 1995, Mol. Endocrinol., 9, 72
Cited by
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
Lefebvre, P., Cariou, B., Lien, F., Kuipers, F., & Staels, B. (2009) · Physiological Reviews · doi:10.1152/physrev.00010.2008 · Cited by 1,678
“These properties, underlining the concerted action of VDR, FXR, PXR, and CAR in protecting against BA toxicity in the liver and intestinal tract (97, 262), may be confounding when analyzing structure-activity relationships.”
BackgroundBile Acid Metabolism and Signaling
Chiang, J. Y. L. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00517.x · Cited by 279
“FXR, PXR and constitutive androstane receptor (CAR) may play a complementary role in detoxification of bile acids and protection against cholestasis (76).”
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
“…conditions results in repression of bile acid synthesis and increases bile acid detoxification and excretion and may therefore protect hepatocytes from bile acid toxicity (Guo et al. 2003; Han and Chiang 2009; Maglich et al. 2002; Staudinger et al. 2001; Xie et al. 2001; Wang et al. 2002).”
Bile acid signaling in metabolic disease and drug therapy
Li, T., & Chiang, J. Y. L. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008201 · Cited by 935
“A number of studies showed that activation of CAR was beneficial for protecting against bile acid toxicity during cholestasis in mice (Guo et al., 2003; Saini et al., 2004; Stedman et al., 2005; Beilke et al., 2009).”
BackgroundApoptosis and Necrosis in the Liver: A Tale of Two Deaths?
Malhi, H., Gores, G. J., & Lemasters, J. J. (2006) · Hepatology · doi:10.1002/hep.21062 · Cited by 691
Primary sclerosing cholangitis
Hirschfield, G. M., Karlsen, T. H., Lindor, K. D., & Adams, D. H. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60096-3 · Cited by 592
“[57,58] The observation that genetic variants of the pregnane X receptor (PXR)may lead to amore aggressive disease course in PSC is therefore an interesting notion in linewith the importance of PXR in animal models of cholestasis.”
Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine
Kim, I., Ahn, S.-H., Inagaki, T., Choi, M., Ito, S., Guo, G. L., Kliewer, S. A., & Gonzalez, F. J. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700330-jlr200 · Cited by 592
“FXR-deficient mice fail to adapt to dietary cholic acid overload and exhibit dyslipidemia with elevated serum cholesterol and triglyceride concentrations (26, 27 ).”
BackgroundInfluentialSelf-citationMeier, P. J., & Stieger, B. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.082201.100300 · Cited by 586
Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis
Kettner, N. M., Voicu, H., Finegold, M. J., Coarfa, C., Sreekumar, A., Putluri, N., Katchy, C. A., Lee, C., Moore, D. D., & Fu, L. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.007 · Cited by 508
“, 2014), activate CAR, which is well known as a potent tumor promoter that drives non-genotoxic hepatocarcinogenesis (Guo et al., 2003; Huang et al., 2005; Yamamoto et al., 2004; Zhang et al., 2004).”
BackgroundInfluentialMolecular physiology of bile acid signaling in health, disease, and aging
Perino, A., Demagny, H., Velazquez-Villegas, L., & Schoonjans, K. (2021) · Physiological Reviews · doi:10.1152/physrev.00049.2019 · Cited by 481
New Modes of Action for Endocrine-Disrupting Chemicals
Tabb, M. M., & Blumberg, B. (2006) · Molecular Endocrinology · doi:10.1210/me.2004-0513 · Cited by 449
Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR
Tolson, A. H., & Wang, H. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.006 · Cited by 386
The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel Paradigms
Meech, R., Hu, D. G., McKinnon, R. A., Mubarokah, S. N., Haines, A. Z., Nair, P. C., Rowland, A., & Mackenzie, P. I. (2019) · Physiological Reviews · doi:10.1152/physrev.00058.2017 · Cited by 368
Wagner, M., Halilbasic, E., Marschall, H., Zollner, G., Fickert, P., Langner, C., Zatloukal, K., Denk, H., & Trauner, M. (2005) · Hepatology · doi:10.1002/hep.20784 · Cited by 355
FXR, a multipurpose nuclear receptor
Lee, F. Y., Lee, H., Hubbert, M. L., Edwards, P. A., & Zhang, Y. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.08.002 · Cited by 344
Bile Acid Metabolism and Signaling in Cholestasis, Inflammation, and Cancer
Li, T., & Apte, U. (2015) · Advances in Pharmacology · doi:10.1016/bs.apha.2015.04.003 · Cited by 333
“uted to the induction of CAR target genes Cpy2b, Cyp3a, Mrp2, Ugt1a1, and Gsta (Guo et al., 2003).”
BackgroundGeier, A., Wagner, M., Dietrich, C. G., & Trauner, M. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.04.014 · Cited by 314
Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis
Gomez-Ospina, N., Potter, C. J., Xiao, R., Manickam, K., Kim, M.-S., Kim, K. H., Shneider, B. L., Picarsic, J. L., Jacobson, T. A., Zhang, J., et al. (2016) · Nature Communications · doi:10.1038/ncomms10713 · Cited by 300
Pascussi, J.-M., Gerbal-Chaloin, S., Duret, C., Daujat-Chavanieu, M., Vilarem, M.-J., & Maurel, P. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105349 · Cited by 298
“The use of transgenic and pxr-null animals support this conclusion (97).”
Emerging roles of bile acids in mucosal immunity and inflammation
Chen, M. L., Takeda, K., & Sundrud, M. S. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0162-4 · Cited by 298
Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects
di Masi, A., Marinis, E. D., Ascenzi, P., & Marino, M. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.04.002 · Cited by 288
Detoxification of Lithocholic Acid, A Toxic Bile Acid: Relevance to Drug Hepatotoxicity
Hofmann, A. F. (2004) · Drug Metabolism Reviews · doi:10.1081/dmr-200033475 · Cited by 268
“Genes that are targeted by bile acid activation of nuclear receptors primary bile acids appear to be those involved in bile acid biosynthesis, conjugation, and transport, as well as members of the cytochrome P450 system, for example, CYP3A4, involved in drug metabolism (Guo et al., 2003).”
BackgroundCoordinate transcriptional regulation of bile acid homeostasis and drug metabolism
Eloranta, J. J., & Kullak-Ublick, G. A. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.09.019 · Cited by 260
Alnouti, Y., Csanaky, I. L., & Klaassen, C. D. (2008) · Journal of Chromatography B · doi:10.1016/j.jchromb.2008.08.018 · Cited by 258
Maher, J. M., Cheng, X., Slitt, A. L., Dieter, M. Z., & Klaassen, C. D. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.003798 · Cited by 255
“In previous studies, TCPOBOP also induced Mrp2 in mice in vivo, correlating well with the present data (Guo et al., 2003).”
ResultZhang, J., Huang, W., Qatanani, M., Evans, R. M., & Moore, D. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409041200 · Cited by 246
Assem, M., Schuetz, E. G., Leggas, M., Sun, D., Yasuda, K., Reid, G., Zelcer, N., Adachi, M., Strom, S., Evans, R. M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314111200 · Cited by 240
Bhalla, S., Ozalp, C., Fang, S., Xiang, L., & Kemper, J. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405423200 · Cited by 230
Stedman, C. A. M., Liddle, C., Coulter, S. A., Sonoda, J., Alvarez, J. G. A., Moore, D. D., Evans, R. M., & Downes, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409794102 · Cited by 228
Chen, Y., Tang, Y., Guo, C., Wang, J., Boral, D., & Nie, D. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.030 · Cited by 219
LAMBA, V (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.12.027 · Cited by 216
Kong, B., Luyendyk, J. P., Tawfik, O., & Guo, G. L. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.144600 · Cited by 210
“Mice with FXR deficiency have severe impairment of bile acid homeostasis (Sinal et al., 2000; Guo et al., 2003) and manifest systemic abnormalities, including altered lipid and cholesterol metabolism (Lambert et al.”
BackgroundMethodSelf-citationBile Acids and FXR: Novel Targets for Liver Diseases
Stofan, M., & Guo, G. L. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00544 · Cited by 197
Self-citationMiao, J., Fang, S., Bae, Y., & Kemper, J. K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510713200 · Cited by 200
Targeting farnesoid X receptor for liver and metabolic disorders
Fiorucci, S., Rizzo, G., Donini, A., Distrutti, E., & Santucci, L. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.06.001 · Cited by 196
Another renaissance for bile acid gastrointestinal microbiology
Ridlon, J. M., & Gaskins, H. R. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00896-2 · Cited by 183
“…distinct bile acids to differentially act as ligands for a complex array of nuclear receptors such as the farnesoid X receptor (FXR; also known as NR1H4) 17,18,19 , pregnane X receptor (PXR; or NR1I2) 20 , vitamin D 3 receptor (VDR) 21 and the constitutive androstane receptor (CAR; or NR1I3) 22 .”
Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation
Thibaut, M. M., & Bindels, L. B. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.12.006 · Cited by 184
Bochkis, I. M., Rubins, N. E., White, P., Furth, E. E., Friedman, J. R., & Kaestner, K. H. (2008) · Nature Medicine · doi:10.1038/nm.1853 · Cited by 186
“), Pxr and Car have been shown to play complementary parts in protecting the liver from bile acid toxicit”
Zollner, G., Wagner, M., Moustafa, T., Fickert, P., Silbert, D., Gumhold, J., Fuchsbichler, A., Halilbasic, E., Denk, H., Marschall, H.-U., et al. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00490.2005 · Cited by 178
“Phase I hydroxylation renders bile acids more hydrophilic and thus less toxic and represents an important mechanism counteracting bile acid-induced liver damage (2,9,24,27,28,30-32,39,44,46).”
The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism
Zhou, C., Verma, S., & Blumberg, B. (2009) · Nuclear Receptor Signaling · doi:10.1621/nrs.07001 · Cited by 178
“Mice lacking both FXR and SXR exhibit more severe disturbances in cholesterol, lipid and bile acid metabolism than mice lacking only one of the two nuclear receptors [Guo et al., 2003].”
BackgroundEstrogen Receptor α Mediates 17α-Ethynylestradiol Causing Hepatotoxicity
Yamamoto, Y., Moore, R., Hess, H. A., Guo, G. L., Gonzalez, F. J., Korach, K. S., Maronpot, R. R., & Negishi, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602723200 · Cited by 178
Self-citationNuclear receptors in bile acid metabolism
Li, T., & Chiang, J. Y. L. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2012.740048 · Cited by 176
“…nuclear receptors in the NR1I subfamily, pregnane X receptor (PXR; NR1I2) (Staudinger et al., 2001), vitamin D receptor (VDR; NR1I1) (Makishima et al., 2002), and constitutive androstane receptor (CAR; NR1I3) (Guo et al., 2003), were shown to be activated by bile acids or bile acid metabolites.”
BackgroundInfluentialRegulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR
Handschin, C., & Meyer, U. A. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.08.030 · Cited by 173
Enterohepatic transport of bile salts and genetics of cholestasis
Pauli-Magnus, C., Stieger, B., Meier, Y., Kullak-Ublick, G. A., & Meier, P. J. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.017 · Cited by 175
“The beneficial effects of treatment with phenobarbital in cholestasis may be due to CAR-mediated induction of hepatic genes involved in bile acid and bilirubin metabolism and excretion [60].”
BackgroundSterol Regulation of Metabolism, Homeostasis, and Development
Wollam, J., & Antebi, A. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-081308-165917 · Cited by 158
Trauner, M., Wagner, M., Fickert, P., & Zollner, G. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000155551.37266.26 · Cited by 164
“Another xenobotic receptor, constitutive androstane receptor (CAR; NR1I3) has recently been shown to be activated by bilirubin, and a role of CAR for sensing bile salts has been postulated.(18) Thus, a picture is emerging where endobiotic and xenobiotic (biliary) compounds share hepatic transport and metabolic systems…”
BackgroundHernandez, J., Mota, L., & Baldwin, W. (2009) · Current Pharmacogenomics and Personalized Medicine · doi:10.2174/187569209788654005 · Cited by 158
FXR and PXR: Potential therapeutic targets in cholestasis
Jonker, J. W., Liddle, C., & Downes, M. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.06.012 · Cited by 167
“Bile acids repress CYP7A1 through FXR-induced expression of SHP, which in turn negatively interacts with several other members of the NR subfamily, including LXR, HNF4α and LRH-1 [22,58,77].”
PXR and CAR: Nuclear Receptors which Play a Pivotal Role in Drug Disposition and Chemical Toxicity
Stanley, L. A., Horsburgh, B. C., Ross, J., Scheer, N., & Roland Wolf, C. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600786232 · Cited by 151
“The induction of mCAR and Cyp2b10 in FXR null and double null mice fed 1% CA, along with the reduction in bile acid and bilirubin levels in FXR null and double null mice given PB or TCPOBOP, suggested that activation of mCAR might contribute to limiting hepatic toxicity by inducing the metabolism of excess bile acids…”
BackgroundThe Flame Retardants, Polybrominated Diphenyl Ethers, Are Pregnane X Receptor Activators
Pacyniak, E. K., Cheng, X., Cunningham, M. L., Crofton, K., Klaassen, C. D., & Guo, G. L. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm025 · Cited by 147
“The details for Northern blot analysis and the bDNA can be found in a previous report (Guo et al., 2003; Hartley and Klaassen, 2000).”
BackgroundSelf-citationNuclear receptors as therapeutic targets in cholestatic liver diseases
Zollner, G., & Trauner, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00030.x · Cited by 146
“, 2002), and ligands for these receptors induce MRP2/Mrp2 expression (Courtois et al., 1999; 2002; Cherrington et al., 2002; Kast et al., 2002; Guo et al., 2003; Marschall et al., 2005; Teng and Piquette-Miller, 2005; Wagner et al., 2005).”
InfluentialCircadian Dysregulation Disrupts Bile Acid Homeostasis
Ma, K., Xiao, R., Tseng, H.-T., Shan, L., Fu, L., & Moore, D. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006843 · Cited by 144
“Disruption of bile acid homeostatic regulation by deletion of FXR leads to elevation in hepatic bile acid levels that results in activation of CAR and PXR and damage to hepatocytes [28,51].”
Wolfe, A. R., Thomas, A., Edwards, G., Jaseja, R., Guo, G. L., & Apte, U. M. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.179390 · Cited by 158
“The role of FXR has been recognized in a variety of physiological and pathological processes, including the regulation of bile acid homeostasis (Guo et al., 2003; Lambert et al., 2003; Eloranta and Kullak-Ublick, 2008; Gadaleta et al., 2010), lipid metabolism, liver regeneration, inflammation, and cancer (Huang et al.”
BackgroundSelf-citationHoffmann, U., & Kroemer, H. K. (2004) · Drug Metabolism Reviews · doi:10.1081/dmr-200033473 · Cited by 165
“hyperforin, rifampicin, nifedipine, dexamethasone, the HIV protease inhibitor ritonavir, the anticancer agents vincristine, tamoxifen or cisplatin, and polycyclic aromatic hydrocarbons induce the MRP2 level in human hepatocytes as well as other detoxifing proteins such as cytochrome P4503A4, 3A1, and P-glycoprotein (D…”
BackgroundThe role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Chow, M. D., Lee, Y.-H., & Guo, G. L. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.04.004 · Cited by 140
“Most BAs and the secondary BA, LCA, are known to bind to FXR and PXR, respectively (Edwards et al., 2002).”
BackgroundSelf-citationWhy Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression
Gottlieb, A., & Canbay, A. E. (2019) · Cells · doi:10.3390/cells8111358 · Cited by 156
“The regulation of BAs on other pathways occurs mainly through the activation of nuclear hormone receptors (NHRs) such as the farnesoid X receptor (FXR), pregnane X receptor (PXR), and vitamin D receptor (VDR) [29,30].”
BackgroundSwales, K., & Negishi, M. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0397 · Cited by 137
Self-citationKodama, S., Moore, R., Yamamoto, Y., & Negishi, M. (2007) · Biochemical Journal · doi:10.1042/bj20070481 · Cited by 136
Self-citationMa, X., Shah, Y. M., Cheung, C., Guo, G. L., Feigenbaum, L., Krausz, K. W., Idle, J. R., & Gonzalez, F. J. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.012831 · Cited by 145
“…primers were used to identify the mouse PXR WT and null alleles: PXR-Fwd1, 5 -CTGGTCATCACTGTTGCTGTACCA-3 ; PXR-Rev2, 5 -GCAGCATAGGACAAGTTATTCTAGAG-3 ; and PXR-Rev3, 5 -CTAAAGCGCATGCTCCAGACTGC-3 amplifying a PCR product of 348 bp for WT allele and 265 bp for Pxr-null allele (Guo et al., 2003).”
Self-citationAlterations in xenobiotic metabolism in the long‐lived Little mice
Amador‐Noguez, D., Dean, A., Huang, W., Setchell, K., Moore, D., & Darlington, G. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00300.x · Cited by 134
The profile of bile acids and their sulfate metabolites in human urine and serum
Bathena, S. P., Mukherjee, S., Olivera, M. A., & Alnouti, Y. (2013) · Journal of Chromatography B · doi:10.1016/j.jchromb.2013.10.019 · Cited by 131
Hepatoprotective role of PXR activation and MRP3 in cholic acid‐induced cholestasis
Teng, S., & Piquette‐Miller, M. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707235 · Cited by 130
“Similar trends have been reported in other nuclear receptor knockout models (Guo et al., 2003; Saini et al., 2005; Marschall et al., 2006).”
ResultFarnesoid X Receptor: From Structure to Potential Clinical Applications
Pellicciari, R., Costantino, G., & Fiorucci, S. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0582221 · Cited by 130
Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasis
Anakk, S., Watanabe, M., Ochsner, S. A., McKenna, N. J., Finegold, M. J., & Moore, D. D. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42846 · Cited by 129
“Moreover, Fxr-knockout (Fxr–/–) mice challenged with cholic acid overload have elevated serum cholesterol and triglyceride levels (10, 29).”
BackgroundNuclear Receptor Signaling in the Control of Cholesterol Homeostasis: Have the Orphans Found a Home?
Ory, D. S. (2004) · Circulation Research · doi:10.1161/01.res.0000143422.83209.be · Cited by 128
Zollner, G., Wagner, M., Fickert, P., Silbert, D., Gumhold, J., Zatloukal, K., Denk, H., & Trauner, M. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01506.x · Cited by 127
Update on primary sclerosing cholangitis
Karlsen, T. H., & Boberg, K. M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.015 · Cited by 122
“One of the major eterminants of the expression of the genes involved in these rocesses is the steroid and xenobiotic receptor (SXR; also called regnane X receptor, PXR) [90,91].”
BackgroundTranscriptional regulation of hepatic stellate cells
Mann, J., & Mann, D. A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.011 · Cited by 119
Update on primary sclerosing cholangitis
Karlsen, T. H., Schrumpf, E., & Boberg, K. M. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.01.011 · Cited by 117
Johnson, B. M., Zhang, P., Schuetz, J. D., & Brouwer, K. L. R. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005793 · Cited by 114
“…of both Mrp3 and UGT1a in the liver of TR rats may result from the activation of a common nuclear hormone receptor, such as the farnesoid X receptor, pregnane X receptor, or constitutive androstane receptor (Schuetz et al., 2001; Chen et al., 2003b; Guo et al., 2003; Zollner et al., 2003).”
BackgroundEvolution of the pregnane x receptor: adaptation to cross-species differences in biliary bile salts
Krasowski, M. D., Yasuda, K., Hagey, L. R., & Schuetz, E. G. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0427 · Cited by 115
“The protective role of PXR in regulating metabolism and elimination of toxic bile acids has been elegantly demonstrated in mouse models (4,15-18).”
BackgroundEnhanced Acetaminophen Toxicity by Activation of the Pregnane X Receptor
Guo, G. L. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh286 · Cited by 112
“The details for the Northern blot analysis have been described in detail previously (Guo et al., 2003).”
MethodSelf-citationWestley, I. S., Brogan, L. R., Morris, R. G., Evans, A. M., & Sallustio, B. C. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.006122 · Cited by 110
“Mrp2-deficient rats develop cholestasis and raised concentrations of bile acids, ligands for nuclear receptors that regulate many aspects of hepatic physiology, including drug-metabolizing enzymes and transporters (Chiang, 2003; Guo et al., 2003).”
BackgroundVitamin D and the risk for cancer: A molecular analysis
Carlberg, C., & Velleuer, E. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114735 · Cited by 123
Vitamin D and evolution: Pharmacologic implications
Hanel, A., & Carlberg, C. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.07.024 · Cited by 109
Rodrigues, A. D., Lai, Y., Cvijic, M. E., Elkin, L. L., Zvyaga, T. A., & Soars, M. G. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.054205 · Cited by 113
“Numerous BAs have been shown to be agonists of these receptors (Guo et al., 2003; Stahl et al., 2008; Li and Chiang, 2013).”
BackgroundCombined loss of orphan receptors PXR and CAR heightens sensitivity to toxic bile acids in mice
Uppal, H., Toma, D., Saini, S. P. S., Ren, S., Jones, T. J., & Xie, W. (2005) · Hepatology · doi:10.1002/hep.20512 · Cited by 106
Sterolins ABCG5 and ABCG8: regulators of whole body dietary sterols
Hazard, S., & Patel, S. B. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-005-0040-7 · Cited by 105
Pawlikowska, L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh100 · Cited by 105
Keitel, V., Dröge, C., & Häussinger, D. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_231 · Cited by 119
Molecular aspects of bile formation and cholestasis
Arrese, M. A., & Trauner, M. (2003) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.10.002 · Cited by 111
Cheng, X., & Klaassen, C. D. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn147 · Cited by 102
“It has been previously shown that FXR-null mice have increased CAR mRNA (Guo et al., 2003).”
BackgroundResultInfluentialTissue-specific function of farnesoid X receptor in liver and intestine
Zhu, Y., Li, F., & Guo, G. L. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2010.12.018 · Cited by 100
“Toxic concentrations of bile acids in the liver also activate PXR and CAR to promote bile acid detoxification and sinusoidal efflux [21,24].”
BackgroundSelf-citationClaudel, T., Zollner, G., Wagner, M., & Trauner, M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.021 · Cited by 110
Auerbach, S. S., Stoner, M. A., Su, S., & Omiecinski, C. J. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.013417 · Cited by 110
“Studies involving genetically modified mice have demonstrated specific roles for CAR in xenobiotic (Wei et al., 2000; Zhang et al., 2002), heme (Huang et al., 2003; Xie et al., 2003), carcinogen (Xie et al., 2003), bile acid ( Guo et al., 2003; Assem et al., 2004; Saini et al., 2004), and thyroid hormone metabolism (M…”
BackgroundRegulation of hepatic bile acid transporters Ntcp and Bsep expression
Cheng, X., Buckley, D. B., & Klaassen, C. D. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.014 · Cited by 98
“Taurocholate and/or cholic acid down-regulated mouse Ntcp via induction of the nuclear repressor short heterodimer partner (SHP) [33,34,60], whereas they up-regulated mouse Bsep expression [23,32,34].”
BackgroundDeKeyser, J. G., Laurenzana, E. M., Peterson, E. C., Chen, T., & Omiecinski, C. J. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfq394 · Cited by 115
“in regulation of metabolism of endogenous compounds such as bile acids (Guo et al. 2003) and”
BackgroundNuclear receptors CAR and PXR in the regulation of hepatic metabolism
Tien, E. S., & Negishi, M. (2006) · Xenobiotica · doi:10.1080/00498250600861827 · Cited by 109
“Pretreatment of mice with PB or TCPOBOP before feeding of cholic acid resulted in significantly reduced bile acid levels (Guo et al. 2003; Wagner et al. 2005).”
BackgroundSelf-citationXue, Y., Moore, L. B., Orans, J., Peng, L., Bencharit, S., Kliewer, S. A., & Redinbo, M. R. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0323 · Cited by 93
Self-citationMcCarthy, T. C., Li, X., & Sinal, C. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411520200 · Cited by 90
Self-citationNuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity
Zollner, G., Wagner, M., & Trauner, M. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.03.005 · Cited by 96
“…but also by endobiotics including the secondary bile acid LCA for PXR (Staudinger et al., 2001; Xie et al., 2001) and bilirubin for CAR, and a role of CAR for sensing bile acids has been suggested (Guo et al., 2003; Huang et al., 2003b; Goodwin & Moore, 2004; Xie et al., 2004; Tirona & Kim, 2005).”
BackgroundPatel, R. D., Hollingshead, B. D., Omiecinski, C. J., & Perdew, G. H. (2007) · Hepatology · doi:10.1002/hep.21671 · Cited by 88
Agolino, G., Pino, A., Vaccalluzzo, A., Cristofolini, M., Solieri, L., Caggia, C., & Randazzo, C. L. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106357 · Cited by 99
Chini, M. G., Jones, C. R., Zampella, A., D’Auria, M. V., Renga, B., Fiorucci, S., Butts, C. P., & Bifulco, G. (2011) · The Journal of Organic Chemistry · doi:10.1021/jo2023763 · Cited by 87
Karlsen, T. H., Vesterhus, M., & Boberg, K. M. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12581 · Cited by 86
Nuclear-receptor–mediated regulation of drug– and bile-acid–transporter proteins in gut and liver
Staudinger, J. L., Woody, S. K., Sun, M., & Cui, W. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2012.748793 · Cited by 88
“, 2003), and a subsequent study further implicated a complimentary and combined role for PXR, FXR, and CAR in protecting against bile-acid–induced hepatotoxicity, in part resulting from induction of MRP3 expression and activity in the liver (Guo et al., 2003).”
Petrick, J. S., & Klaassen, C. D. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.015974 · Cited by 85
“Furthermore, CAR activation by TCPOBOP augmented cholic acid induction of mouse biotransformation enzymes and uptake transporters (Guo et al., 2003).”
Vitamin D: A master example of nutrigenomics
Carlberg, C., Raczyk, M., & Zawrotna, N. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102695 · Cited by 107
Attia, Y. M., Tawfiq, R. A., Ali, A. A., & Elmazar, M. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-12629-4 · Cited by 82
DeKeyser, J. G., Stagliano, M. C., Auerbach, S. S., Prabhu, K. S., Jones, A. D., & Omiecinski, C. J. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.053702 · Cited by 87
“…modulating the metabolism of a variety of pharmaceuticals, such as acetaminophen (Zhang et al., 2002) and cyclophosphamide (Roy et al., 1999), as well as endogenous compounds, including thyroid hormone (Maglich et al., 2004), bile acids (Guo et al., 2003), and steroid hormones (Xie et al., 2003).”
Background
Metadata
- Authors
- Guo, G. L., Lambert, G., Negishi, M., Ward, J. M., Brewer, H. B., Kliewer, S. A., Gonzalez, F. J., & Sinal, C. J.
- Affiliations
- National Institutes of Health (US)
- Inserm (FR)
- National Cancer Institute (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Gonzalez, Frank J.
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-11
- Volume
- 278
- Issue
- 46
- Pages
- 45062-45071
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2168485100
- Cited by
- 312
- References
- 37
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 7 · 2023: 10 · 2022: 7 · 2021: 8 · 2020: 10 · 2019: 9 · 2018: 9 · 2017: 10 · 2016: 6 · 2015: 6 · 2014: 9 · 2013: 20 · 2012: 13
- FWCI
- 11.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6175 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- farnesoid X receptor, pregnane X receptor, constitutive androstane receptor, bile acid toxicity, cholic acid, bile acid homeostasis, cholesterol homeostasis, lipid homeostasis, cholestasis, bilirubin metabolism, phenobarbital, TCPOBOP, CYP2B, CYP3A, MRP2, MRP3, UGT1A, alpha-glutathione S-transferase
- MeSH terms
- Pregnane X Receptor, Constitutive Androstane Receptor, Receptor, Farnesoid X-Activated, Animals, Animal Feed, Aryl Hydrocarbon Hydroxylases, Bile Acids and Salts, Bilirubin, Biological Transport, Body Weight, Cell Nucleus, Cholesterol, Cloning, Molecular, Crosses, Genetic, DNA-Binding Proteins, Glutathione Transferase, Liver, Mice, Transgenic, Oxidoreductases, N-Demethylating, Phenobarbital, Phospholipids, Pyridines, Receptors, Steroid, Ribosomal Proteins, Time Factors, Transcription Factors, Blotting, Northern, Up-Regulation, Gene Deletion, Receptors, Cytoplasmic and Nuclear, Mitochondrial Proteins, Saccharomyces cerevisiae Proteins, Lipid Metabolism, Mice, Cytochrome P-450 CYP3A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.